We are excited to announce that Catalyst is partnering with Better Therapeutics to study the effectiveness of digital cognitive behavioral therapy approaches to treat type 2 diabetes in clinically integrated primary care settings.
Read the full release to find out more about how we're working together to help communities thrive and pushing the boundaries of what's possible for patients with chronic conditions.
Catalyst Joins Better Therapeutics Study of Digital Diabetes Treatment